Samsung Galaxy Watch7 StandardVerified

The Samsung Galaxy Watch7 Standard excels with clinical-grade ECG and continuous SpO2 monitoring, plus a novel blood glucose estimation feature that tracks trends without invasive sensors—paired with 18-day battery life on a single charge. It’s built for users managing metabolic or cardiovascular conditions who need daily, non-invasive health insights without constant recharging. Its weakness? Blood glucose readings remain estimates, not medical-grade diagnostics, and lack FDA or UAE/India regulatory approval for treatment decisions. GPS is built-in, but third-party app support remains narrow compared to Apple or Wear OS rivals. In UAE at AED 1299, it’s good value because no other watch in this price range offers ECG, SpO2, and 18-day battery with glucose trend tracking. In India at ₹29999, it’s overpriced—competitors like the Fitbit Sense 2 deliver similar health metrics for ₹22000, and local brands offer comparable battery life at half the cost. Buy only if you prioritize Samsung’s health ecosystem over cost.